Iterum Therapeutics
Troy Whelan is a seasoned professional in the pharmaceutical industry, currently serving as the Senior Director of Quality at Iterum Therapeutics plc since May 2019, where responsibilities include overseeing quality-related activities for the development and production of oral solid dose products and managing compliance with regulatory guidance. Prior to this role, Troy held leadership positions such as Director of Quality and Director of Drug Product and Analytical Development at Iterum, as well as Analytical Services Manager at Iterum Therapeutics Ltd., and QC Manager at Takeda Ireland Limited. Troy's extensive experience also includes roles at Helsinn Birex, Pfizer Grange Castle, and Biovail Technologies. Educational achievements include a Master of Science in Pharmaceutical Manufacturing Technology from Trinity College Dublin and advanced GDP training from PLS Pharma.
This person is not in any teams
This person is not in any offices
Iterum Therapeutics
2 followers
Iterum Therapeutics Limited is dedicated to developing significantly differentiated anti-infectives aimed at combatting MDR pathogens.